Molecular xenomonitoring using mosquitoes to map lymphatic filariasis after mass drug administration in American Samoa

PLoS Negl Trop Dis. 2014 Aug 14;8(8):e3087. doi: 10.1371/journal.pntd.0003087. eCollection 2014 Aug.

Abstract

Background: Mass drug administration (MDA) programs have dramatically reduced lymphatic filariasis (LF) incidence in many areas around the globe, including American Samoa. As infection rates decline and MDA programs end, efficient and sensitive methods for detecting infections are needed to monitor for recrudescence. Molecular methods, collectively termed 'molecular xenomonitoring,' can identify parasite DNA or RNA in human blood-feeding mosquitoes. We tested mosquitoes trapped throughout the inhabited islands of American Samoa to identify areas of possible continuing LF transmission after completion of MDA.

Methodology/principle findings: Mosquitoes were collected using BG Sentinel traps from most of the villages on American Samoa's largest island, Tutuila, and all major villages on the smaller islands of Aunu'u, Ofu, Olosega, and Ta'u. Real-time PCR was used to detect Wuchereria bancrofti DNA in pools of ≤ 20 mosquitoes, and PoolScreen software was used to infer territory-wide prevalences of W. bancrofti DNA in the mosquitoes. Wuchereria bancrofti DNA was found in mosquitoes from 16 out of the 27 village areas sampled on Tutuila and Aunu'u islands but none of the five villages on the Manu'a islands of Ofu, Olosega, and Ta'u. The overall 95% confidence interval estimate for W. bancrofti DNA prevalence in the LF vector Ae. polynesiensis was 0.20-0.39%, and parasite DNA was also detected in pools of Culex quinquefasciatus, Aedes aegypti, and Aedes (Finlaya) spp.

Conclusions/significance: Our results suggest low but widespread prevalence of LF on Tutuila and Aunu'u where 98% of the population resides, but not Ofu, Olosega, and Ta'u islands. Molecular xenomonitoring can help identify areas of possible LF transmission, but its use in the LF elimination program in American Samoa is limited by the need for more efficient mosquito collection methods and a better understanding of the relationship between prevalence of W. bancrofti DNA in mosquitoes and infection and transmission rates in humans.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aedes / parasitology*
  • Animals
  • Culex / parasitology*
  • DNA, Helminth / analysis
  • DNA, Helminth / genetics
  • Elephantiasis, Filarial* / drug therapy
  • Elephantiasis, Filarial* / epidemiology
  • Elephantiasis, Filarial* / transmission
  • Filaricides / therapeutic use
  • Humans
  • Molecular Epidemiology
  • Wuchereria bancrofti / classification
  • Wuchereria bancrofti / genetics*

Substances

  • DNA, Helminth
  • Filaricides

Associated data

  • Dryad/10.5061/dryad.704G1

Grants and funding

Funding for this research was provided by Bill and Melinda Gates Foundation grants 43922 awarded to the Lymphatic Filariasis Support Center at the Task Force for Global Health and 44190 awarded to the University of Kentucky. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.